Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Phase 1/2 study of lumasiran in patients with PH1
.
Show all posts
Showing posts with label
Phase 1/2 study of lumasiran in patients with PH1
.
Show all posts
Wednesday, September 12, 2018
Alnylam announces new positive results from Phase 1/2 study of lumasiran in patients with PH1
›
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced new positive results from its Phase 1/2 study with lumasir...
›
Home
View web version
